Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis
Interleukin-25 has been reported to have anticancer activity with very little effect on non-malignant cells. Here, the authors show that a synthetic phytochemical can be used to induce the secretion of Interleukin-25 from tumour associated fibroblasts resulting in impaired tumour metastasis.
Guardado en:
Autores principales: | Shu-Yi Yin, Feng-Yin Jian, Yung-Hsiang Chen, Shih-Chang Chien, Mao-Chih Hsieh, Pei-Wen Hsiao, Wen-Hwa Lee, Yueh-Hsiung Kuo, Ning-Sun Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b854c0abfbef4aea9b063916b10162c6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Erratum: Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis
por: Shu-Yi Yin, et al.
Publicado: (2016) -
A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours
por: Rong Fu, et al.
Publicado: (2019) -
Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis
por: Raymond K. H. Yip, et al.
Publicado: (2021) -
Eradication of unresectable liver metastasis through induction of tumour specific energy depletion
por: Da Huo, et al.
Publicado: (2019) -
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis
por: Ute Jungwirth, et al.
Publicado: (2021)